Related references
Note: Only part of the references are listed.Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward
Richard A. Slivicki et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain
Jenny L. Wilkerson et al.
BRAIN AND BEHAVIOR (2020)
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence
Vishakh Iyer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro
Richard A. Slivicki et al.
PHARMACOLOGICAL RESEARCH (2019)
CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain
Elisa Nent et al.
SCIENTIFIC REPORTS (2019)
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
Francesca Gado et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal
Ai-Ling Li et al.
MOLECULAR PHARMACOLOGY (2019)
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Yurii Saroz et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2019)
Merkel cells: A collective review of current concepts
Jacob Abraham et al.
INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH (2019)
Slowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence
Xiaoyan Lin et al.
MOLECULAR PHARMACOLOGY (2018)
Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life
Christine Miaskowski et al.
JOURNAL OF CANCER SURVIVORSHIP (2018)
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease
Alicia Lopez et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice
Wan-Hung Lee et al.
PAIN (2018)
Keratinocytes mediate innocuous and noxious touch via ATP-P2X4 signaling
Francie Moehring et al.
ELIFE (2018)
Molecular Architecture of the Mouse Nervous System
Amit Zeisel et al.
CELL (2018)
ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOSIAP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability
Wan-Hung Lee et al.
MOLECULAR PAIN (2018)
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A. Slivicki et al.
BIOLOGICAL PSYCHIATRY (2018)
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit
Richard A. Slivicki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy
Justin G. Lees et al.
EUROPEAN JOURNAL OF CANCER (2017)
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice
Lawrence M. Carey et al.
SCIENTIFIC REPORTS (2017)
Targeting cytokines for treatment of neuropathic pain
Alice L. Hung et al.
SCANDINAVIAN JOURNAL OF PAIN (2017)
Cross-Laboratory Analysis of Brain Cell Type Transcriptomes with Applications to Interpretation of Bulk Tissue Data
B. Ogan Mancarci et al.
ENEURO (2017)
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release
Fang Gao et al.
MOLECULAR NEUROBIOLOGY (2016)
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain
Karen Krukowski et al.
JOURNAL OF NEUROSCIENCE (2016)
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
Yong Li et al.
NEURAL PLASTICITY (2016)
Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo
Richard A. Slivicki et al.
PLOS ONE (2016)
Dermatological adverse events with taxane chemotherapy
Vincent Sibaud et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
CaMKII Controls Whether Touch Is Painful
Hongwei Yu et al.
JOURNAL OF NEUROSCIENCE (2015)
Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics
Wan-Hung Lee et al.
NEUROPHARMACOLOGY (2015)
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
V. A. Carozzi et al.
NEUROSCIENCE LETTERS (2015)
Selective keratinocyte stimulation is sufficient to evoke nociception in mice
Zixuan Pang et al.
PAIN (2015)
Keratinocytes can modulate and directly initiate nociceptive responses
Kyle M. Baumbauer et al.
ELIFE (2015)
CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain
Liting Deng et al.
MOLECULAR PHARMACOLOGY (2015)
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
Yannick Marchalant et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
Elizabeth J. Rahn et al.
MOLECULAR PAIN (2014)
Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
Ivana Hradilova Svizenska et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
Sean P. Hollinshead et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia
Jacqueline R. Dauch et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB2 receptor
Jean-Ha Baek et al.
JOURNAL OF NEUROSCIENCE METHODS (2013)
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
Jill Bouchard et al.
JOURNAL OF NEUROSCIENCE (2012)
Spinal Interleukin-10 Therapy to Treat Peripheral Neuropathic Pain
Erin D. Milligan et al.
NEUROMODULATION (2012)
Epidermal Langerhans cells in small fiber neuropathies
Jordi Casanova-Molla et al.
PAIN (2012)
Keratinocyte expression of calcitonin gene-related peptide β: Implications for neuropathic and inflammatory pain mechanisms
Quanzhi Hou et al.
PAIN (2011)
Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyperalgesia and can be prevented by treatment with minocycline
J. Boyette-Davis et al.
PAIN (2011)
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Elizabeth J. Rahn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Antinociceptive Effects of Racemic AM1241 and Its Chirally Synthesized Enantiomers: Lack of Dependence upon Opioid Receptor Activation
Elizabeth J. Rahn et al.
AAPS JOURNAL (2010)
The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines
Paul J. Austin et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Natural history of cutaneous innervation following herpes zoster
Karin Lottrup Petersen et al.
PAIN (2010)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Nucleotide signaling and cutaneous mechanisms of pain transduction
G. Dussor et al.
BRAIN RESEARCH REVIEWS (2009)
Skin biopsy for the diagnosis of peripheral neuropathy
G. Lauria et al.
HISTOPATHOLOGY (2009)
TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons
Kelvin Y. Kwan et al.
JOURNAL OF NEUROSCIENCE (2009)
Molecular Identification of Rapidly Adapting Mechanoreceptors and Their Developmental Dependence on Ret Signaling
Wenqin Luo et al.
NEURON (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: Evidence for a role in pain
Peng Zhao et al.
PAIN (2008)
Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors
Aleksandra Ellert-Miklaszewska et al.
BRAIN RESEARCH (2007)
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
Cristina Benito et al.
JOURNAL OF NEUROSCIENCE (2007)
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis
T. Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Pathophysiology of peripheral neuropathic pain: Immune cells and molecules
Michael A. Thacker et al.
ANESTHESIA AND ANALGESIA (2007)
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells
Chiang Siau et al.
EXPERIMENTAL NEUROLOGY (2006)
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
M Beltramo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin
S Ständer et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2005)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons
G Wotherspoon et al.
NEUROSCIENCE (2005)
TrkC kinase expression in distinct subsets of cutaneous trigeminal innervation and nonneuronal cells
U Fünfschilling et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Thalidomide inhibits tumor necrosis factor-α production and antigen presentation by Langerhans cells
L Deng et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury
A Khodorova et al.
NATURE MEDICINE (2003)
Relief of post-herpetic neuralgia by surgical removal of painful skin
KL Petersen et al.
PAIN (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
CB2 cannabinoid receptor-mediated peripheral antinociception
TP Malan et al.
PAIN (2001)
Share Paper
